BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34823306)

  • 1. Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.
    Yoon JH; Jin M; Kim M; Hong AR; Kim HK; Kim BH; Kim WB; Shong YK; Jeon MJ; Kang HC
    Endocrinol Metab (Seoul); 2021 Dec; 36(6):1268-1276. PubMed ID: 34823306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
    Premoli P; Tanda ML; Piantanida E; Veronesi G; Gallo D; Masiello E; Rosetti S; Cusini C; Boi F; Bulla J; Rodia R; Mariotti S; Capelli V; Rotondi M; Magri F; Chiovato L; Rocchi R; Campopiano MC; Elisei R; Vitti P; Barbato F; Pilli T; Castagna MG; Pacini F; Bartalena L
    J Endocrinol Invest; 2020 Jan; 43(1):109-116. PubMed ID: 31327128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of thyroid cancer in patients with Graves' disease.
    Ren M; Wu MC; Shang CZ; Wang XY; Zhang JL; Cheng H; Xu MT; Yan L
    World J Surg; 2014 Jan; 38(1):80-7. PubMed ID: 24166025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of papillary thyroid cancer in patients with Graves' disease: a propensity score-matched analysis.
    Kwon H; Moon BI
    World J Surg Oncol; 2020 Oct; 18(1):266. PubMed ID: 33050937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid carcinoma in patients with Graves' disease: an institutional experience.
    Wei S; Baloch ZW; LiVolsi VA
    Endocr Pathol; 2015 Mar; 26(1):48-53. PubMed ID: 25332114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
    You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
    J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistent thyroid nodules in patients with graves' disease: What is the frequency and the risk of malignancy?
    Shi HH; McHenry CR
    Am J Surg; 2018 Nov; 216(5):980-984. PubMed ID: 30049435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' disease and papillary thyroid carcinoma: case report and literature review of a single academic center.
    Arosemena MA; Cipriani NA; Dumitrescu AM
    BMC Endocr Disord; 2022 Aug; 22(1):199. PubMed ID: 35945543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
    Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
    J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental thyroid carcinoma in patients with Graves' disease.
    Phitayakorn R; McHenry CR
    Am J Surg; 2008 Mar; 195(3):292-7; discussion 297. PubMed ID: 18206132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism.
    Berker D; Isik S; Ozuguz U; Tutuncu YA; Kucukler K; Akbaba G; Aydin Y; Guler S
    Endocrine; 2011 Feb; 39(1):13-20. PubMed ID: 21061094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy.
    Cappelli C; Braga M; De Martino E; Castellano M; Gandossi E; Agosti B; Cumetti D; Pirola I; Mattanza C; Cherubini L; Rosei EA
    Surg Today; 2006; 36(2):125-30. PubMed ID: 16440157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncological alertness in Graves disease].
    Ryabchenko EV
    Khirurgiia (Mosk); 2023; (6):56-61. PubMed ID: 37313702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid nodules as a risk factor for thyroid cancer in patients with Graves' disease: A systematic review and meta-analysis of observational studies in surgically treated patients.
    Papanastasiou A; Sapalidis K; Goulis DG; Michalopoulos N; Mareti E; Mantalovas S; Kesisoglou I
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):571-577. PubMed ID: 31369161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease?
    Tamatea JA; Tu'akoi K; Conaglen JV; Elston MS; Meyer-Rochow GY
    ANZ J Surg; 2014 Apr; 84(4):231-4. PubMed ID: 22985335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience.
    Ergin AB; Saralaya S; Olansky L
    Am J Otolaryngol; 2014; 35(6):784-90. PubMed ID: 25128909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased aggressiveness of thyroid cancer in patients with Graves' disease.
    Belfiore A; Garofalo MR; Giuffrida D; Runello F; Filetti S; Fiumara A; Ippolito O; Vigneri R
    J Clin Endocrinol Metab; 1990 Apr; 70(4):830-5. PubMed ID: 2180978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
    Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
    Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Graves' disease with associated thyroid nodules (nodular Graves' disease). Clinical, diagnostic and therapeutic considerations].
    Lamata Hernández F; Sánchez Beorlegui J; Artigas Marco MC; González González M; Martínez Díez M
    An Med Interna; 2003 Aug; 20(8):403-9. PubMed ID: 14516260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
    Park J; An S; Bae JS; Kim JS; Kim K
    Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.